What is IFRX's current stock price?

As of now, IFRX is trading at $1.00, with a daily change of -6.54%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

IFRX Stock Analysis & IQ Rating | InflaRx N.V.

IFRX

InflaRx N.V.

$1.00

-$0.07 | -6.54%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$2.77

MKT CAP

$67.75M

52W Low

$0.71

VOL

$525.10K

P/E Ratio

N/A

AVG VOL

$725.03K

RSI

43.13

TREND

Downtrend

IFRX Stock IQ

Login to see InflaRx N.V. (IFRX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

IFRX Target Price

Login to display

Strengths

IFRX Rewards

Earnings are forecast to grow

IFRX Price Performance

$1.01 (-0.99%)

$1.35 (-25.93%)

$0.91 (+9.89%)

$2.39 (-58.16%)

1year

6month

3month

1month

IFRX Risk Level

IFRX has Extreme risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Price under $5

High volatilty

Extreme

LOW

HIGH

IFRX Analysts Opinion

IFRX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

IFRX Analysts Opinion

IFRX Analysts opinion is negative and it remained unchanged from the past 3 months

IFRX Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

75%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

NA

0%

100%

IFRX Street Sentiment

IFRX Street Sentiment is bullish and have positive views on the near-term outlook

IFRX Performance Sentiment

Sentiments overview associated with IFRX events and the stock performance.

75%

25%

Positive

Negative

3 out of 4
events present

1 out of 4
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$1.07

Resistance
Price

$1.00

Current Price Range

$1.20

Show methods +

Linked to IFRX

IQ

Close Price

Change

SNY

3.94

47.47

-0.88%

MRK

4.24

110.95

-0.06%

MLTX

4.19

16.35

-6.09%

LLY

4.21

1032.97

-3.76%

INSM

4.11

159.27

-2.56%

Explore our IFRX Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored IFRX Stock Strategies
Effective Risk Management

FIND US ON

Receive our IFRX Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

IFRX

InflaRx N.V.

Set Alerts

Current Price

$1.00

-$0.07 | -6.54%

52W High

$2.77

MKT CAP

$67.75M

52W Low

$0.71

VOL

$525.10K

P/E Ratio

N/A

AVG VOL

$725.03K

RSI

43.13

TREND

Downtrend

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

IFRX Stock IQ

Login to unlock InflaRx N.V. (IFRX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Target Price

Login to display

Stock Insights

Strengths

IFRX Rewards

Earnings are forecast to grow

Linked to IFRX

Symbol

IQ

Close

Change

SNY

3.94

47.47

-0.88%

MRK

4.24

110.95

-0.06%

MLTX

4.19

16.35

-6.09%

LLY

4.21

1032.97

-3.76%

INSM

4.11

159.27

-2.56%

IFRX Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

75%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

NA

0%

100%

IFRX Street Sentiment

IFRX Street Sentiment is bullish and have positive views on the near-term outlook

IFRX Risk Level

IFRX has Extreme risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Price under $5

High volatilty

Extreme

LOW

HIGH

IFRX Performance Sentiment

Sentiments overview associated with IFRX events and the stock performance.

75%

25%

Positive

Negative

3 out of 4
events present

1 out of 4
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$1.07

Resistance
Price

$1.00

Current Price Range

$1.20

Show methods +

IFRX Latest Analysis

InflaRx Plans Workforce Reduction Targets Mid-2027 Cash Runway. ) on thursday said it is taking decisive steps to cut costs streamline operations and extend its cash runway as it sharpens its focus on izicopan its lead investigational asset while significantly scaling back .Gohibic is a medicine used to treat acute respiratory distress syndrome due to COVID-19 infection.The company said the changes are intended to improve capital efficiency and support further development of izicopan across hidr

Thu Jan 8, 2026

$1.09 | -9.17%

Activity

Potential

InflaRx Reopens Case For Axed Phase 3 Drug For Rare Skin Disorder. ) is reviving hopes for vilobelimab after new analyses showed signs of efficacy in a Phase 3 trial it had previously halted setting up FDA talks and a potential partner-led path forward.Last Tuesday the company outlined multiple data analyses of the Phase 3 study for vilobelimab in pyoderma gangrenosum (PG) which was terminated earlier in 2025 after an Independent Data Monitoring Committee (IDMC) recommended the trial be .Subsequ

Mon Jan 5, 2026

$1.14 | +4.59%

Activity

InflaRx Shares In-Dept Analysis About Vilobelimab Stock Down In Pre-Market . (RTTNews) - InflaRx N.V. (IFRX) Tuesday announced updates regarding its Phase 3 study for vilobelimab in pyoderma gangrenosum which was terminated earlier this year after an Independent Data Monitoring Committee recommended the trial be stopped early due to futility.

Tue Dec 30, 2025

$1.02 | 0.00%

Momentum

Discover IFRX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of IFRX. We're here to help you make informed investment decisions today.

FIND US ON

Receive our IFRX Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

IFRX Stock trends

IFRX Stock performance

IFRX Stock analysis

IFRX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing IFRX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing IFRX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

IFRX Stock Analysis & IQ Rating | InflaRx N.V.

IFRX Stock IQ

IFRX Target Price

IFRX Risk Level

IFRX Analysts Opinion

IFRX Street Sentiment

IFRX Performance Sentiment

Technical Price Levels

Explore our IFRX Stock insights

Receive our IFRX Daily Alerts

IFRX Street Sentiment

IFRX Risk Level

Technical Price Levels

Discover IFRX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of IFRX. We're here to help you make informed investment decisions today.

Receive our IFRX Daily Alerts

IFRX Alerts